Insights Into Intra-Cellular Therapies Inc (ITCI) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

Intra-Cellular Therapies Inc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Intra-Cellular Therapies Inc is $7.63B. A total of 0.52 million shares were traded on the day, compared to an average of 614.85K shares.

In the most recent transaction, ALEXANDRIA VENTURE INVESTMENTS bought 25,000 shares of ITCI for 73.17 per share on Sep 06 ’24. In a previous transaction on Aug 29 ’24, Mates Sharon sold 35,604 shares at 72.57 per share. ITCI shares that Chairman and CEO owns now total 1,070,329.

Among the insiders who sold shares, Mates Sharon disposed of 34,396 shares on Aug 30 ’24 at a per-share price of $72.84. This resulted in the Chairman and CEO holding 1,070,329 shares of ITCI after the transaction. In another insider transaction, Mates Sharon bought 34,396 shares at $72.78 per share on Aug 30 ’24.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ITCI has a high of $84.89 and a low of $45.50.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ITCI’s latest balance sheet shows that the firm has $412.33M in Cash & Short Term Investments as of fiscal 2021. There were $25.41M in debt and $53.36M in liabilities at the time. Its Book Value Per Share was $10.84, while its Total Shareholder’s Equity was $417.89M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ITCI is Buy with a score of 4.60.

Most Popular

Related Posts